Have some news you want to share with the Oregon Bio community? Fill out our submission form.
AbSci Establishes New Collaboration with Sanofi
AbSci and Sanofi entered into a collaboration to improve the manufacturability for two of Sanofi’s biotherapeutics
VANCOUVER, Wash., Jan. 9, 2019 /PRNewswire/
AbSci, a global leader in biotherapeutic discovery and manufacturing technologies, today announced a collaboration with Sanofi. Under the terms of the agreement, AbSci will apply its breakthrough E.coli manufacturing platform, SoluProTM, and its novel optimization assay system, to two of Sanofi’s biotherapeutic molecules. AbSci’s proprietary technology platform is designed with the ability to rapidly achieve optimized, scalable, […]
Veana Therapeutics secures NIH funding for VIMO
Veana Therapeutics is pleased to announce a Phase I Small Business Innovation Research (SBIR) grant award from the NIH National Cancer Institute to conduct proof-of-concept pre-clinical studies of its lead product, VIMO (Veana Immune Modulator) in combination with immune checkpoint inhibitors in triple negative breast cancer. Learn more about Veana here.
DesignMedix Inc. wins PBJ’s Manufacturer of the Year (1-10 employees)
By Denise Szott – Contributing writer for Portland Business Journal
The Portland company developed a drug to cure malaria that is easy and cheap to manufacture
DesignMedix co-founder and Chief Scientific Officer David Peyton and a student carry out research at the DesignMedix Lab in the Portland State
Most of us have felt annoyed by the itchy red bump left by a mosquito dining on our blood. But in many parts of […]
Portland wearables maker gets $1.6M grant for physical therapy system
Elizabeth Hayes, Portland Business Journal
The system is a fraction of the cost of traditional rehab systems, such as instrumented treadmills, which run $80,000, according to APDM. STOCKSTUDIOX
A Portland wearables developer has landed $1.6 million as it helps older adults achieve independent movement.
The National Institute on Aging grant will help APDM […]
How a $600M jolt could get OHSU’s promising AIDS vaccine to market
Elizabeth Hayes, Portland Business Journal
ANDREW TOWNSEND OHSU VACCINE & GENE THERAPY INSTITUTE
When TomegaVax Inc. spun out from Oregon Health & Science University in 2011, it had the makings of a future bio-star.
The startup would commercialize the research from the OHSU Vaccine and Gene Therapy Institute, where Dr. Louis Picker and his colleagues were developing a vaccine to combat some of the greatest global health crises in the world — HIV/AIDS, malaria and tuberculosis. […]
Madison High graduate to attend Brown University as first-generation college student
Corlyn Vorhees, The Oregonian/Oregon Live
Madison High graduate Cynthia Bui will be attending Brown University in September.
Cynthia Bui, who graduated from Madison High this week, started preparing for college when she was only 10.
She was the “really annoying know-it-all kid,” she said. “I genuinely enjoyed learning. I don’t think that’s changed. It’s gotten worse as I’ve gotten older.”
Bui learned three languages: Vietnamese by speaking it at […]
Eugene firm employs worms to transform drug research
Elizabeth Hayes, Portland Business Journal
The following story is part of this week’s package on the winners of the Portland Business Journal’s Small Business Innovation Awards.
Eugene-based NemaMetrix uses nematode worms to help scientists save money and time as they determine if a drug has therapeutic value or potentially dangerous side effects.
The startup’s ScreenChip System collects data after DNA from a human patient is injected into the worm, an excellent living proxy for a human.
“Honestly, I believe we’re […]
AbSci raises $12 million in Series C financing
Elizabeth Hayes, Portland Business Journal
AbSci, which developed a technology to drive down the cost of insulin for treating diabetes, said Wednesday it has raised $12 million.
The oversubscribed Series C financing round will fuel commercialization of AbSci’s protein expression platform. SaluPro can accelerate biopharmaceutical discovery and development and reduce manufacturing costs.
The Vancouver, Washington-based company also announced that AGC Biologics President and CEO Dr. Gustavo Mahler will join AbSci’s board of directors. AGC, the parent company […]
Veana Therapeutics Announces Interim Results of the Phase I Trial for VIMO-001
Developing innovative immunotherapy products that effectively treat cancer patients and have minimal impact on their quality of life.
FOR IMMEDIATE PRESS RELEASE
April 5, 2018
Veana Therapeutics, Inc. is pleased to announce the interim results of the Phase I safety trial of its lead cancer immunotherapy drug asset, VIMO-001, in patients with advanced cancer. The Phase I clinical study is an “all comers” trial of patients with advanced and diverse cancer indications, including pancreatic, lung, prostate, renal, esophageal, colon, head and neck, and […]
Portland biotech community finally gets its wish: a new lab-office project
Elizabeth Hayes, Portland Business Journal
Summit Development Group to invest $12M in Central Eastside lab-office development
One of the biggest obstacles for biotech companies looking to expand in Portland is the city’s lack of suitable lab space.
That situation is about to change. A new 40,000-square-foot lab-office development, scheduled to get underway in April, is slated to open in the fall in Portland’s Central Eastside.
Summit Development Group bought a 100-year-old, three-story warehouse building on the corner of Southeast Eighth Avenue and Alder Street […]
